To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT03856619 · COMPLETED
Trial details
- NCT number
- NCT03856619
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2022-05-13
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.